Literature DB >> 15627818

Analysis of adrenergic regulation of melatonin synthesis in Siberian hamster pineal emphasizes the role of HIOMT.

R M Ceinos1, M Chansard, F Revel, C Calgari, J M Míguez, V Simonneaux.   

Abstract

Seasonal variations of environmental factors are translated into annual fluctuations in synthesis and release of melatonin, which in turn acts as a neuroendocrine messenger for the synchronization of annual functions. So far, most studies performed to understand the regulation of melatonin synthesis have used the non seasonal laboratory rat. It was demonstrated that nocturnal melatonin synthesis depends on alpha- and beta-adrenergic activation of the enzyme arylalkylamine N-acetyltransferase (AA-NAT). In this study, we investigated the mechanisms of melatonin synthesis in the Siberian hamster, a seasonal species with marked photoperiodic variation in melatonin peak duration and amplitude. A beta-adrenergic receptor agonist alone markedly stimulated AA-NAT activity and melatonin synthesis and release. An alpha-adrenergic receptor agonist, while having no effect per se, potentiated the beta-adrenergic stimulation of AA-NAT activity both in vitro and in vivo. Strikingly, the potentiation of AA-NAT activity did not result in a potentiation of melatonin synthesis, suggesting that the rate of melatonin production is limited downstream in the metabolic pathway, most probably at the level of hydroxyindole-O-methyltransferase (HIOMT). HIOMT presented a constitutively high activity that was not acutely (within hours) stimulated by beta-adrenergic agonist, but was rather up-regulated by chronic application of the agonist. This long-term beta-adrenergic regulation may explain the reported large photoperiodic variation of HIOMT activity that drives the photoperiodic variation in melatonin peak. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627818     DOI: 10.1159/000081966

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  7 in total

Review 1.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Night/day changes in pineal expression of >600 genes: central role of adrenergic/cAMP signaling.

Authors:  Michael J Bailey; Steven L Coon; David A Carter; Ann Humphries; Jong-So Kim; Qiong Shi; Pascaline Gaildrat; Fabrice Morin; Surajit Ganguly; John B Hogenesch; Joan L Weller; Martin F Rath; Morten Møller; Ruben Baler; David Sugden; Zoila G Rangel; Peter J Munson; David C Klein
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

3.  Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system.

Authors:  Dun-Xian Tan; Lucien C Manchester; Emilio Sanchez-Barcelo; Maria D Mediavilla; Russel J Reiter
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 4.  The Reserve/Maximum Capacity of Melatonin's Synthetic Function for the Potential Dimorphism of Melatonin Production and Its Biological Significance in Mammals.

Authors:  Dun-Xian Tan; Rüdiger Hardeland
Journal:  Molecules       Date:  2021-12-02       Impact factor: 4.411

5.  Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis.

Authors:  Cezary Chojnacki; Janusz Błasiak; Jakub Fichna; Jan Chojnacki; Tomasz Popławski
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

Review 6.  Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism.

Authors:  Dun-Xian Tan; Lucien C Manchester; Eduardo Esteban-Zubero; Zhou Zhou; Russel J Reiter
Journal:  Molecules       Date:  2015-10-16       Impact factor: 4.411

7.  Temporal expression patterns of the melatoninergic system in the human thymus of children.

Authors:  Ivan Cruz-Chamorro; Nuria Álvarez-Sánchez; Cristina Escalante-Andicoechea; Antonio Carrillo-Vico; Amalia Rubio; Juan Miguel Guerrero; Patrocinio Molinero; Patricia J Lardone
Journal:  Mol Metab       Date:  2019-07-24       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.